SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
74 hedge funds and large institutions have $94.3M invested in Strongbridge Biopharma plc. in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
1% less capital invested
Capital invested by funds: $95.3M → $94.3M (-$941K)
Holders
74
Holding in Top 10
1
Calls
$527K
Puts
$252K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$1.04M | |
| 3 | +$1.03M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$719K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$538K |
Top Sellers
| 1 | -$4.82M | |
| 2 | -$3.88M | |
| 3 | -$3.53M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.5M |
| 5 |
Renaissance Technologies
New York
|
-$1.77M |